scholarly journals Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24‐Week, Phase III Study

2019 ◽  
Vol 44 (4) ◽  
pp. 621-631 ◽  
Author(s):  
Samuel A. Kocoshis ◽  
Russell J. Merritt ◽  
Susan Hill ◽  
Susan Protheroe ◽  
Beth A. Carter ◽  
...  
Keyword(s):  
Short Bowel Syndrome ◽  
Pediatric Patients ◽  
Intestinal Failure ◽  
Phase Iii ◽  
Safety And Efficacy ◽  
Short Bowel ◽  
Phase Iii Study

Su2008 A PHASE III STUDY OF TEDUGLUTIDE IN ADULT JAPANESE PATIENTS WITH SHORT BOWEL SYNDROME–ASSOCIATED INTESTINAL FAILURE

2020 ◽  
Vol 158 (6) ◽  
pp. S-742
Author(s):  
Motoshi Wada ◽  
Tsunekazu Mizushima ◽  
Akira Sugita ◽  
Yuko Tazuke ◽  
Eri Udagawa ◽  
...  
Keyword(s):  
Short Bowel Syndrome ◽  
Intestinal Failure ◽  
Japanese Patients ◽  
Phase Iii ◽  
Short Bowel ◽  
Phase Iii Study

Neonatal and Pediatric Parenteral Nutrition

2012 ◽  
Vol 23 (4) ◽  
pp. 451-464 ◽  
Author(s):  
Anne Gargasz
Keyword(s):  
Parenteral Nutrition ◽  
Short Bowel Syndrome ◽  
Pediatric Patients ◽  
Intestinal Failure ◽  
Nutritional Requirements ◽  
Gastrointestinal Fistula ◽  
Short Bowel ◽  
Therapeutic Modalities ◽  
The 1960S

Parenteral nutrition is one of the most important therapeutic modalities invented in the last several decades. Since its introduction in the 1960s, this modality has saved thousands of lives by providing nutrients parenterally to sustain growth in premature neonates with severe intestinal immaturity and other pediatric patients with intestinal failure, such as a gastrointestinal fistula or short bowel syndrome. Although parenteral nutrition can be a lifesaving treatment, it is not benign. Many complications can result from either short- or long-term usage. This review discusses the nutritional requirements, common complications, medication additives, and special considerations for pediatric patients requiring parenteral nutrition.

Sign in / Sign up

Export Citation Format

Share Document